4Basecare Onco Solutions Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 16-12-2024
- Paid Up Capital ₹ 3.56 M
as on 16-12-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 823.20%
(FY 2022)
- Profit -41.73%
(FY 2022)
- Ebitda 7.67%
(FY 2022)
- Net Worth 25.72%
(FY 2022)
- Total Assets 279.51%
(FY 2022)
About 4Basecare Onco Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.56 M, as per Ministry of Corporate Affairs (MCA) records.
Hitesh Madan and Kshitij Rishi serve as directors at the Company.
- CIN/LLPIN
U85100KA2020FTC138091
- Company No.
138091
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
03 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at 4Basecare Onco Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Madan  | Director | 03-Sep-2020 | Current |
| Kshitij Rishi | Director | 03-Sep-2020 | Current |
Financial Performance of 4Basecare Onco Solutions.
4Basecare Onco Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 823.2% increase. The company also saw a substantial fall in profitability, with a 41.73% decrease in profit. The company's net worth Soared by an impressive increase of 25.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 4Basecare Onco Solutions?
In 2022, 4Basecare Onco Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
4Basecare Genomics Private LimitedActive 6 years 8 monthsHitesh Madan and Kshitij Rishi are mutual person
- 4Basecare Precision Health Private LimitedActive 9 months 28 days
Hitesh Madan and Kshitij Rishi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at 4Basecare Onco Solutions?
4Basecare Onco Solutions has a workforce of 135 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 4Basecare Onco Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 4Basecare Onco Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
